USPTO serial 79425256
ADIPOPHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 16, 2026
- Examiner
- HUDSON, TAMARA BREE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ADIPOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; medications for human medicine for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for medical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for pharmaceutical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; diagnostic preparations for medical use; cultures of microorganisms for medical use; stem cells for medical use; sanitary preparations for medical purposes; foodstuffs and dietetic food and beverages adapted for medical or veterinary use | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design relating to drugs, pharmaceuticals, medicine; research and development services in the field of pharmacy and in particular medicines; research and development of new products for third parties; biological research; bacteriological research; chemical research; cosmetic science research; technical research in the field of new product development; scientific laboratory services; chemical analysis; material testing; technical project studies namely, conducting of feasibility studies in the field of new technologies; surveying being engineering services, engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 16, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 28, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 22, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 16, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 8, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 11, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 5, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |